| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 55, 660-661, Copyright © 1977 by American Heart Association
P Steele, JH Ellis Jr, HS Weily and E Genton
Platelet survival time (autologous labeling with 51chromium) was measured
in 63 patients in order to evaluate the role of platelets in the
thromboembolic complications of patients with hypoxemia and pulmonary
hypertension. Thirty-eight of these patients had chronic obstructive
airways disease; 13, primary pulmonary hypertension; seven, recurrent
pulmonary embolism; four, the Eisenmenger syndrome; and one, multiple
pulmonary arteriovenous fistula. Forty-three patients were hypeakly
associated with arterial oxygen tension ( r = 0.50), but not with the
arterial carbon dioxide tension or the level of pulmonary artery pressure.
Sulfinpyrazone lengthened platelet survival in 12 of 24 (50%) treated
patients but this drug did not alter either arterial oxygen tension
arterial carbon dioxide tension, or pulmonary artery pressure. Our results
suggest that hypoxemia is associated with shortened platelet survival time
and that platelets may, therefore, be involved in the thromboembolic
complications that develop in patients with hypoxemia.
ARTICLES
Platelet survival time in patients with hypoxemia and pulmonary hypertension
This article has been cited by other articles:
![]() |
C. K. Silversides, J. T. Granton, E. Konen, M. A. Hart, G. D. Webb, and J. Therrien Pulmonary thrombosis in adults with Eisenmenger syndrome J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1982 - 1987. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Egermayer, G I. Town, and A. J Peacock Role of serotonin in the pathogenesis of acute and chronic pulmonary hypertension Thorax, February 1, 1999; 54(2): 161 - 168. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1977 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |